Abstract:We have reported that epoxyeicosatrienoic acids (EETs), the cytochrome P450 (CYP) epoxygenase metabolites of arachidonic acid (AA), are potent sarcolemmal ATP‐sensitive K+ (KATP) channel activators. However, activation of cardiac and vascular KATP channels by endogenously produced EETs under physiological intracellular conditions has not been demonstrated and direct comparison of the mechanisms whereby EETs activate the KATP channels in cardiac myocytes versus vascular smooth muscle cells has not been made. In this study, we examined the effects of AA on KATP channels in freshly isolated cardiac myocytes from rats, wild‐type (WT) and transgenic mice overexpressing CYP2J2 cDNA, and mesenteric arterial smooth muscle cells from rats. We also compared the activation of cardiac and vascular KATP channels by extracellularly and intracellularly applied 11,12‐EET. We found that 1 μm AA enhanced KATP channel activities in both cardiac and vascular smooth muscle cells, and the AA effects were inhibited by preincubation with CYP epoxygenase inhibitors. Baseline cardiac KATP current densities in CYP2J2 transgenic mice were 190% higher than those of WT mice, and both were reduced to similar levels by CYP epoxygenase inhibition. Western blot analysis showed that expression of Kir6.2 and SUR2A was similar between WT and CYP2J2 transgenic hearts. 11,12‐EET (5 μm) applied intracellularly enhanced the KATP currents by 850% in cardiac myocytes, but had no effect in vascular smooth muscle cells. In contrast, 11,12‐EET (5 μm) applied extracellularly increased KATP currents by 520% in mesenteric arterial smooth muscle cells, but by only 209% in cardiac myocytes. Preincubation with 100 μmm‐iodobenzylguanidine or 5 μm myristoylated PKI amide did not alter the activation of cardiac KATP channels by 5 μm 11,12‐EET, but significantly inhibited activation of vascular KATP channels. Moreover, EET only enhanced the inward component of cardiac KATP currents, but activated both the inward and outward components of vascular KATP currents. Our results indicate that endogenously derived CYP metabolites of AA potently activate cardiac and vascular KATP channels. EETs regulate cardiac electrophysiology and vascular tone by KATP channel activation, albeit through different mechanisms: the cardiac KATP channels are directly activated by EETs, whereas activation of the vascular KATP channels by EETs is protein kinase A dependent.

A Soluble Epoxide Hydrolase Inhibitor—8-Hude Increases Pulmonary Vasoconstriction Through Inhibition of KATP Channels

Progress on the Treatment for Hypertension of Epoxide Hydrolase and Its Mechanisms

Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid.

Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels

Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A1 receptor-dependent contraction in mouse mesenteric arteries: role of ATP-sensitive K+ channels

Soluble Epoxide Hydrolase Inhibitor t-AUCB Ameliorates Vascular Endothelial Dysfunction by Influencing the NF-κB/miR-155-5p/eNOS/NO/IκB Cycle in Hypertensive Rats

Activation of rat mesenteric arterial K<sub>ATP</sub> channels by 11,12-epoxyeicosatrienoic acid

Angiotensin II Up-Regulates Soluble Epoxide Hydrolase in Vascular Endothelium in Vitro and in Vivo.

CALL FOR PAPERS Regulation of Cardiovascular Functions by Eicosanoids and Other Lipid Mediators Mechanism of Rat Mesenteric Arterial KATP Channel Activation by 14,15-Epoxyeicosatrienoic Acid

Abstract 973: Angiotensin II Up-Regulates Soluble Epoxide Hydrolase in Vascular Endothelial Cells

Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid.

Soluble Epoxide Hydrolase: A Potential Target for Metabolic Diseases.

Hydrogen Sulfide As Endothelium-Derived Hyperpolarizing Factor Sulfhydrates Potassium Channels

Mechanism of rat mesenteric arterial K<sub>ATP</sub> channel activation by 14,15-epoxyeicosatrienoic acid

Soluble Epoxide Hydrolase: A Potential Target for Metabolic Diseases

Cardiac and Vascular K-Atp Channels in Rats Are Activated by Endogenous Epoxyeicosatrienoic Acids Through Different Mechanisms

Inhibition of Soluble Epoxide Hydrolase Attenuates Airway Remodeling in a Chronic Asthma Model.

Linking an Insect Enzyme to Hypertension: Angiotensin II-epoxide Hydrolase Interactions.

[Effect of Heme Oxygenase-1 on Hydrogen Peroxide Induced Hypo-Responses in Vascular Contraction].

Soluble Epoxide Hydrolase is Involved in the Development of Atherosclerosis and Arterial Neointima Formation by Regulating Smooth Muscle Cell Migration.

Cellular mechanisms and intracellular signaling pathways for the modulation of eNOS in pulmonary arteries by 15-HETE